Skip to main content

Table 1 Schedule of assessments.

From: Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)

 

Baseline

Month 3

Month 6

Month 9

Month 12

Adherence*

X

X

X

X

X

MSSES

X

   

X

MSQoL-54

X

 

X

 

X

Adverse Events

X

X

X

X

X

Relapses

X

X

X

X

X

EDSS**

X

   

X

DAQ-90

    

X

DRS

X

    
  1. *, and at 6 additional random time points
  2. **, optional
  3. MSSES, Multiple Sclerosis Self Efficacy Scale
  4. MSQoL-54, Multiple Sclerosis Quality of Life-54
  5. EDSS, Expanded Disability Status Scale
  6. DAQ-90, Dutch Adherence Questionnaire-90
  7. DRS, Discontinuation Risk Score
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us